Aguilar-Olivos NE, Gutiérrez-Grobe Y, Motola M, Lavenant I, Uribe M, Méndez-Sánchez N

Language: Spanish
References: 11
Page: 124-126
PDF size: 106.50 Kb.

ABSTRACT

Background. Hepatocellular carcinoma (HCC) usually occurs in the setting of cirrhosis, however many patients develop HCC without this major risk factor. The aim of this study was to describe the prevalence of hepatocellular carcinoma among non-cirrhotic patients. Material and methods. A cross-sectional study was performed at Medica Sur Hospital and Clinic Foundation in Mexico City. We obtained the HCC prevalence among non-cirrhotic liver according histological findings. Results. From January 2005 to April 2012 we evaluated 47 hepatocellular carcinoma cases. The prevalence of this condition among non-cirrhotic patients was 19%.Conclusions. Hepatocellular carcinoma may occur in the absence of cirrhosis. The prevalence found in Mexico is similar to that reported in the literature.

REFERENCES

1. Alkofer B, Lepennec V, Chiche L. Hepatocellularcancer in the non-cirrhoticliver. J Visc Surg 2011; 148: 3-11.

2. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors and screening. Semin Liver Dis 2005; 25: 143-54.

3. Decaens T, Laurent A, Luciani A. Liver transplantation for hepatocellular carcinoma in non-cirrhotic livers regardless of the numbers and size of tumours? J Hepatol 2012; 57: 235-36.

4. Borie F, Bouvier AM, Herrero A, Faivre J, Launoy G, Delafosse P, Velten M, et al. Treatment and prognosis of hepatocellular carcinoma: A population based study in France. J Surg Onco 2008; 98(7): 505-9

5. Truant S, Boleslawski E, Duhamel A. Tumor size of hepatocellular carcinoma in noncirrhoticliver. A controversial predictive factor for outcome after resection. ESJO 2012; 38: 1189-96.

6. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27: 1485-91.

7. Morineaux E, Marion-Audibert AM, Merle P, Ardene S, Bancel B, Baulieux J, Zoulim F, et al Hepatocellular carcinoma in a noncirrhotic Oliver: Presentation of a Medico-surgical series of 40 cases. AGA abstracts 321. Gastroenterology 2008; 134(4): Suppl. 1: A46.

8. Farazi PA, De Pinho RA. Hepatocellular carcinoma pathogenesis from genes to environment. Nat Rev Cancer 2006; 6: 674-87.

9. Aguilar-Olivos N, Ornelas-Arroyo S, Chávez-Tapia NC, Uribe M, Méndez-Sánchez N. New insights in the diagnosis, pathogenesis and treatment of Hepatitis B and C related hepatocellular carcinoma. Curr Hepatitis Rep 2013; 12: 297-304.

10. Kaibori M, Ishizaki M, Matsui K, Kwon AH. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J Surg Oncol 2010; 102: 462-8.

11. Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005; 11: 1086-92.